Zobrazeno 1 - 10
of 578
pro vyhledávání: '"di Ioia, M."'
Autor:
di Ioia, M., Di Stefano, V., Farina, D., Di Tommaso, V., Travaglini, D., Pietrolongo, E., Sensi, S.L., Onofrj, M., De Luca, G.
Publikováno v:
In Multiple Sclerosis and Related Disorders February 2020 38
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 893-914 (2013)
Alessandra Lugaresi,1 Maria di Ioia,1 Daniela Travaglini,1 Erika Pietrolongo,1 Eugenio Pucci,2 Marco Onofrj11Department of Neuroscience and Imaging, University “G d’Annunzio”, Chieti, 2Operative Unit Neurologia ASUR Marche Area Vasta 3, Macerat
Externí odkaz:
https://doaj.org/article/7b438cb53dd941848ca4021e62484fa1
Autor:
Brown J, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson O, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N, Onofrj M, De Luca G, Di Tommaso V, Travaglini D, Pietrolongo E, di Ioia M, Farina D, Mancinelli L, Hodgkinson S, Oreja-Guevara C, Boz C, Prevost J, Olascoaga J, Van Wijmeersch B, Barnett M, Verheul F, Rojas J, Spitaleri D, Rio M, Taylor B, Sanchez-Menoyo J, Ramo-Tello C, Solaro C, Csepany T, Iuliano G, Skibina O, Petersen T, Bolanos R, Sidhom Y, Riadh, Vucic S, Macdonell R, Sempere A, Simo M, Kister I, Shuey N, Radek, Dominguez J, Amato M, Saladino M, Kermode A, Butler E, Moore F, Hughes S, McDonnell G, Piroska I, Yamout B, Soysal A, Ozakbas S, Zwanikken C, MSBase Study Grp
Publikováno v:
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
IMPORTANCE Within 2 decades of onset, 80% of untreated patients with relapsing-remitting multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary progressiveMS. The association between disease-modifying treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8b61f3fe6c67e947d45053132ac505a0
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8031
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8031
Autor:
Prosperini, L, Annovazzi, P, Boffa, L, Buscarinu, Mc, Gallo, A, Matta, M, Moiola, L, Musu, L, Perini, P, Avolio, C, Barcella, V, Bianco, A, Farina, D, Ferraro, E, Pontecorvo, S, Granella, F, Grimaldi, Lme, Laroni, A, Lus, G, Patti, F, Pucci, E, Pasca, M, Sarchielli, P, Ghezzi, A, Zaffaroni, M, Baroncini, D, Buttari, F, Centonze, D, Fornasiero, A, Salvetti, M, Docimo, R, Signoriello, E, Tedeschi, G, Bertolotto, A, Capobianco, M, Comi, G, Cocco, E, Gallo, P, Puthenparampil, M, Grasso, R, Di Francescantonio, V, Rottoli, Mr, Mirabella, M, Lugaresi, A, De Luca, G, Di Ioia, M, Di Tommaso, V, Mancinelli, L, Di Battista, G, Francia, A, Ruggieri, S, Pozzilli, C, Curti, E, Tsantes, E, Palmeri, B, Lapucci, C, Mancardi, Gl, Uccelli, A, Chisari, C, D'Amico, E, Cartechini, E, Repice, Am, Magnani, E, Massaccesi, L, Calabresi, P, Di Filippo, M, Di Gregorio, M, Italian Alemtuzumab Study, Group.
Publikováno v:
Journal of neurology. 265(12)
In this retrospective, multicenter, real-world study we collected clinical and magnetic resonance imaging (MRI) data of all patients (n = 40) with relapsing-remitting multiple sclerosis (RRMS) treated with alemtuzumab according to a "free-of-charge"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5d247585195cd879af5006a1512cd8
https://pubmed.ncbi.nlm.nih.gov/30259178
https://pubmed.ncbi.nlm.nih.gov/30259178
Autor:
Ghezzi, A, Zaffaroni, M, Bianchi, A, Pozzilli, C, Prosperini, L, Borriello, G, Filippi, M, Moiola, L, Gerevini, S, Rocca, MA, Martinelli, V, Comi, G, Grimaldi, LM, Bucello, S, Lus, G, Rinaldi, F, Gallo, P, Trojano, M, Provinciali, L, Pucci, E, Bortolon, F, Capra, R, Coniglio, G, Gasperini, C, Lugaresi, A, Pietrolongo, E, Farina, D, Di Ioia, M, Milani, N, Rottoli, MR, Sarchielli, P., BRESCIA MORRA, VINCENZO, LANZILLO, ROBERTA
Publikováno v:
Multiple Sclerosis Journal. 19:1106-1112
Background: Limited information is available on the use of natalizumab (NA) in pediatric multiple sclerosis (ped-MS) patients. Objective: The purpose of this study was to describe the long-term effects of NA in a large cohort of active ped-MS patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd8956e1d7bf34c52295406296c0e04
https://doi.org/10.1177/1352458512471878
https://doi.org/10.1177/1352458512471878
Autor:
Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tola MR, Troiano M, Zaffaroni M, Malucchi S, Italian Multiple Sclerosis Study group, GALLO, Antonio, TEDESCHI, Gioacchino
Interferon beta (IFNβ) was the first specific disease-modifying treatment licensed for relapsing-remitting multiple sclerosis, and is still one of the most commonly prescribed treatments. A strong body of evidence supports the effectiveness of IFNβ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6009c2492ab610c1af9f7aea43051d1d
http://hdl.handle.net/20.500.11769/53516
http://hdl.handle.net/20.500.11769/53516
Autor:
Rispoli MG; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Valentinuzzi S; Analytical Biochemistry and Proteomics Research Unit, Centre for Advanced Studies and Technology (CAST), University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Pharmacy, 'G. d'Annunzio' University of Chieti-Pescara, 66100 Chieti, Italy., De Luca G; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Del Boccio P; Analytical Biochemistry and Proteomics Research Unit, Centre for Advanced Studies and Technology (CAST), University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Pharmacy, 'G. d'Annunzio' University of Chieti-Pescara, 66100 Chieti, Italy., Federici L; Analytical Biochemistry and Proteomics Research Unit, Centre for Advanced Studies and Technology (CAST), University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Di Ioia M; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Digiovanni A; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Grasso EA; Department of Paediatrics, 'G. d'Annunzio' University of Chieti-Pescara, 66100 Chieti, Italy., Pozzilli V; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Villani A; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Chiarelli AM; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Onofrj M; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy., Wise RG; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Pieragostino D; Analytical Biochemistry and Proteomics Research Unit, Centre for Advanced Studies and Technology (CAST), University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Tomassini V; Institute for Advanced Biomedical Technologies (ITAB), Department of Neurosciences, Imaging and Clinical Sciences, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy.; Department of Neurology, 'SS. Annunziata' University Hospital, 66100 Chieti, Italy.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 15; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 15.
Autor:
Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A, Bridge Study Group
Publikováno v:
BMC Neurology
BMC Neurology, Vol 12, Iss 1, p 7 (2012)
BMC Neurology, Vol 12, Iss 1, p 7 (2012)
Background Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de61811e2dc8950a3f578afd112718b
http://hdl.handle.net/2108/68449
http://hdl.handle.net/2108/68449
Autor:
Borreani, Claudia, Giordano, Andrea, Falautano, Monica, Lugaresi, Alessandra, Martinelli, Vittorio, Granella, Franco, Tortorella, Carla, Plasmati, Imma, Radaelli, Marta, Farina, Deborah, Dalla Bella, Eleonora, Bianchi, Elisabetta, Acquarone, Nicola, Miccinesi, Guido, Solari, Alessandra, D'Alessandro, R., Pucci, E., Uccelli, M. M., Trojano, M., Heesen, C., Mancardi, G. L., Milanese, C., Calabrese, D., Ferrari, G., Mattarozzi, K., Confalonieri, P., Antozzi, C., Maggi, L., Mantegazza, R., Martinelli, V., Colombo, B., Esposito, F., Moiola, L., Rodegher, M., Immovilli, P., De Luca, Giovanna, Di Tommaso, V., Di Ioia, M., Travaglini, D., Pietrolongo, E., Zimatore, G.
Background The SIMS-Trial (ISRCTN81072971) proved the effectiveness, in terms of patient's knowledge and care satisfaction, of an add-on information aid (personal interview with a physician using a navigable CD and take-home booklet) in 120 newly dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::e6a56466960fd6283582053494fb7106
Autor:
Giordano, A, Uccelli, Mm, Pucci, E, Martinelli, V, Borreani, C, Lugaresi, A, Trojano, M, Granella, F, Confalonieri, P, Radice, D, Solari, A, D'Alessandro, R, Heesen, C, Mancardi, Gl, Milanese, C, Galimberti, S, Calabrese, D, Ferrari, G, Mattarozzi, K, Antozzi, C, Lauria, G, La Mantia, L, Pedotti, R, Mantegazza, R, Maggi, L, Colombo, B, Esposito, F, Moiola, L, Rodegher, M, Radaelli, M, Immovilli, P, Dalla Bella, E, De Luca, G, Mattoscio, M, Di Ioia, M, Pace, M, Travaglini, D, Maruotti, V, Farina, D, Zimatore, G, Plasmati, I, Tortorella, C.
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 16(1)
There are few studies on patient knowledge in multiple sclerosis (MS), and only two published questionnaires. The objective of this article was to develop and validate the MS Knowledge Questionnaire (MSKQ), a self-assessed instrument for newly diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4b77408f0901b046464caa828863b7
https://pubmed.ncbi.nlm.nih.gov/19995834
https://pubmed.ncbi.nlm.nih.gov/19995834